Deccan Health Care Reports Mixed Financial Results Amidst Rising Sales in December 2024
Deccan Health Care's financial results for the quarter ending December 2024 show a mixed performance, with net sales reaching Rs 20.43 crore, the highest in five quarters. However, operating profit and profit margins declined, indicating challenges in operational efficiency and overall profitability for shareholders.
Deccan Health Care has recently reported its financial results for the quarter ending December 2024, revealing a mixed performance within the pharmaceuticals and drugs sector. The company achieved net sales of Rs 20.43 crore, marking the highest figure in the last five quarters and reflecting a notable growth compared to the previous four-quarter average of Rs 16.30 crore. This positive trend in sales indicates a potential strengthening in market demand.However, the results also highlight challenges for Deccan Health Care. The operating profit for the quarter was recorded at Rs 0.59 crore, the lowest in the past five quarters, which suggests a decline in operational efficiency. Additionally, the operating profit margin fell to 2.89%, indicating a decrease in profitability. Profit before tax, along with earnings per share, also reached their lowest points in the same timeframe, pointing to a decline in overall profitability for shareholders.
In light of these developments, Deccan Health Care has experienced an adjustment in its evaluation, with its score shifting to 4 from -2 over the last three months.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
